Search hospitals > Georgia > Atlanta
Atlanta Diabetes Associates
Claim this profileAtlanta, Georgia 30318
Global Leader in Diabetes
Global Leader in Type 1 Diabetes
Conducts research for Type 2 Diabetes
Conducts research for Cardiovascular Disease
Conducts research for Low Blood Sugar
113 reported clinical trials
2 medical researchers
Summary
Atlanta Diabetes Associates is a medical facility located in Atlanta, Georgia. This center is recognized for care of Diabetes, Type 1 Diabetes, Type 2 Diabetes, Cardiovascular Disease, Low Blood Sugar and other specialties. Atlanta Diabetes Associates is involved with conducting 113 clinical trials across 44 conditions. There are 2 research doctors associated with this hospital, such as Bruce Bode, MD and Quentin Van Meter, M.D..Top PIs
Bruce Bode, MDAtlanta Diabetes Associates1 year of reported clinical research
Studies Type 1 Diabetes
Studies Diabetes
18 reported clinical trials
27 drugs studied
Quentin Van Meter, M.D.Van Meter Pediatric Endocrinology, P.C.3 years of reported clinical research
Studies Pituitary Dwarfism
Studies Endocrine Disorders
1 reported clinical trial
1 drug studied
Clinical Trials running at Atlanta Diabetes Associates
Type 1 Diabetes
Diabetes
Cardiovascular Disease
Obesity
Turner Syndrome
Syndrome
Kidney Disease
Chronic Kidney Disease
Noonan Syndrome
Small for Gestational Age, Turner Syndrome, Noonan Syndrome, Intrauterine Growth Restriction.
Finerenone
for Chronic Kidney Disease in Type 1 Diabetes
This trial is testing finerenone, a drug that helps protect kidneys and hearts, in people with chronic kidney disease and type 1 diabetes. The study aims to see how well finerenone works in slowing down kidney damage. Researchers will also monitor the safety of the drug by tracking any medical issues participants experience. Finerenone has been shown to delay the progression of chronic kidney disease and reduce cardiovascular events in patients with diabetic kidney disease, particularly type 2 diabetes.
Recruiting1 award Phase 37 criteria
Hybrid Closed Loop System
for Type 1 Diabetes
The purpose of this study is to evaluate the safety and effectiveness of the Hybrid Closed Loop system (HCL) in adult and pediatric patients with type 1 diabetes in the home setting. A diverse population of patients with type 1 diabetes will be studied. The study population will have a large range for duration of diabetes and glycemic control, as measured by glycosylated hemoglobin (A1C). They will be enrolled in the study regardless of their prior diabetes regimen, including using Multiple Daily Injections (MDI), Continuous Subcutaneous Insulin Infusion (CSII) or Sensor-Augmented Pump therapy (SAP)
Recruiting1 award N/A17 criteria
HDV-Insulin Lispro
for Type 1 Diabetes
The goal of this study is to see if directing insulin to the liver will improve the low blood sugar that sometimes happens when injecting insulin in Type 1 diabetes patients. Participants will use continuous glucose monitoring to measure the sugar levels in their blood, and work with the doctor to find the best doses. One group of patients will get the liver targeting insulin, and the other group will use insulin they normally use for treating Type 1 diabetes. The participant will be part of the study for up to 32 weeks.
Recruiting1 award Phase 2
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Atlanta Diabetes Associates?
Atlanta Diabetes Associates is a medical facility located in Atlanta, Georgia. This center is recognized for care of Diabetes, Type 1 Diabetes, Type 2 Diabetes, Cardiovascular Disease, Low Blood Sugar and other specialties. Atlanta Diabetes Associates is involved with conducting 113 clinical trials across 44 conditions. There are 2 research doctors associated with this hospital, such as Bruce Bode, MD and Quentin Van Meter, M.D..